IDH2 and neoplasm: To evaluate DNA methylation changes associated with IDH-mutant glioma progression, we analyzed the number of DMPs between paired tumors of individual patients (“temporal intratumor DMPs”) and between tumor groups (i.e. unpaired primary vs. recurrent tumors).